Previous Article | Next Article ![]()
Mol Cell Biol, July 1998, p. 3889-3899, Vol. 18, No. 7
Infectious Disease Laboratory, The Salk
Institute for Biological Studies, La Jolla, California
92037,1 and
Laboratory of Leukocyte
Biology, National Cancer Institute-Frederick Cancer Research
and Development Center, Frederick, Maryland 217022
Received 20 February 1998/Returned for modification 23 March
1998/Accepted 17 April 1998
The Rev protein of equine infectious anemia virus (ERev) exports
unspliced and partially spliced viral RNAs from the nucleus. Like
several cellular proteins, ERev regulates its own mRNA by mediating an
alternative splicing event. To determine the requirements for these
functions, we have identified ERev mutants that affect RNA export or
both export and alternative splicing. Mutants were further
characterized for subcellular localization, nuclear-cytoplasmic shuttling, and multimerization. None of the nuclear export signal (NES)
mutants are defective for alternative splicing. Furthermore, the NES of
ERev is similar in composition but distinct in spacing from other
leucine-rich NESs. Basic residues at the C terminus of ERev are
involved in nuclear localization, and disruption of the C-terminal
residues affects both functions of ERev. ERev forms multimers, and no
mutation disrupts this activity. In two mutants with substitutions of
charged residues in the middle of ERev, RNA export is affected. One of
these mutants is also defective for ERev-mediated alternative splicing
but is identical to wild-type ERev in its localization, shuttling, and
multimerization. Together, these results demonstrate that the two
functions of ERev both require nuclear import and at least one other
common activity, but RNA export can be separated from alternative
splicing based on its requirement for a functional NES.
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Differential Requirements for Alternative
Splicing and Nuclear Export Functions of Equine Infectious Anemia
Virus Rev Protein

*
Corresponding author. Mailing address: Infectious
Disease Laboratory, The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800. Phone: (619) 453-4100, ext. 1559. Fax:
(619) 554-0341. E-mail: hope{at}salk.edu.
Present address: Department of Molecular Microbiology, Smith-Kline
Beecham Pharmaceuticals, Collegeville, PA 19426.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|